Hydrolysis of phosphatidylinositol 4,5 bisphosphate (PIP2) by phosphatidylinositol specific phospholipase C (PLC) is a central process in hormone regulated signal transduction. We, and others, recently identified a novel, multifunctional PLC, PLCe, regulated by both Ras related GTPases and heterotrimeric GTP binding proteins and thus, potentially downstream of both G protein coupled and growth factor receptors. Despite extensive knowledge of potential regulators of PLCe based on biochemical and overexpression experiments, the true pathways involving PLCe that function in vivo remain undefined. In the previous funding period we created a mouse model with targeted deletion of the PLCe gene. Our exciting central finding from analysis of the phenotype of these mice is that PLCe activity plays a critical role in the PAR signaling pathway in cardiac myocytes critical for supporting ionotropic responses to PAR stimulation. Analyzing this pathway in a true physiological context will allow us to understand signaling properties of this pathway relevant to human disease.
The specific aims are 1) Defining roles for a novel Epac/ PLCe pathway in cardiac function. The proposed experiments are designed to understand the significance of an additional pAR-dependent pathway in cardiac regulation. 2) Examination of the mechanisms for Epac/PLCe regulation of cardiac calcium induced calcium release. We have developed preliminary data supporting a mechanism where Epac-PLCe regulates Ca2+ transients by, at least in part, regulating activity of L-type Ca2+ channels through PKC dependent phosphorylation. 3) Roles for PLCe P Pz hydrolysis and RapGEF activities in cardiac myocytes. Our hypothesis is that PIP2 hydrolysis activity regulates Ca2+ transients but that the RapGEF activity may potentiate this pathway and feed into other critical cardiac signaling pathways that may also be relevant to other physiological systems. 4) Determining if PLCe expression directly in cardiac myocytes protects against development of cardiac hypertrophy. Our preliminary data indicate that treated PLCe -/- animals have increased sensitivity to chronic isoproterenol induced hypertrophy. Here we will measure development of hypertrophy in mice with cardiac specific deletion or overexpression of PLCe to determine if PLCe activity directly in myocytes is cardioprotective. These studies will elucidate a novel mechanism for action of a critical pathway in the cardiovascular system, the p-adrenergic system, p-adrenergic receptors regulate critical cardiac, vascular and pulmonary function. Elucidation of the functions and mechanisms of this novel Epac/PLCe pathway could lead to novel therapeutic strategies for heart failure, pulmonary disease and hypertension.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM053536-12
Application #
7796849
Study Section
Hypertension and Microcirculation Study Section (HM)
Program Officer
Dunsmore, Sarah
Project Start
1996-09-30
Project End
2011-03-31
Budget Start
2010-04-01
Budget End
2011-03-31
Support Year
12
Fiscal Year
2010
Total Cost
$312,543
Indirect Cost
Name
University of Rochester
Department
Pharmacology
Type
Schools of Dentistry
DUNS #
041294109
City
Rochester
State
NY
Country
United States
Zip Code
14627
Strazza, Marianne; Azoulay-Alfaguter, Inbar; Peled, Michael et al. (2017) PLC?1 regulates SDF-1?-induced lymphocyte adhesion and migration to sites of inflammation. Proc Natl Acad Sci U S A 114:2693-2698
Tong, Jiaqing; Liu, Xiaojie; Vickstrom, Casey et al. (2017) The Epac-Phospholipase C? Pathway Regulates Endocannabinoid Signaling and Cocaine-Induced Disinhibition of Ventral Tegmental Area Dopamine Neurons. J Neurosci 37:3030-3044
Kim, Kyun-Do; Bae, Seyeon; Capece, Tara et al. (2017) Targeted calcium influx boosts cytotoxic T lymphocyte function in the tumour microenvironment. Nat Commun 8:15365
DiStefano, Peter V; Smrcka, Alan V; Glading, Angela J (2016) Phospholipase C? Modulates Rap1 Activity and the Endothelial Barrier. PLoS One 11:e0162338
Bijli, Kaiser M; Fazal, Fabeha; Slavin, Spencer A et al. (2016) Phospholipase C-? signaling mediates endothelial cell inflammation and barrier disruption in acute lung injury. Am J Physiol Lung Cell Mol Physiol 311:L517-24
Smrcka, Alan V (2015) Regulation of phosphatidylinositol-specific phospholipase C at the nuclear envelope in cardiac myocytes. J Cardiovasc Pharmacol 65:203-10
Kalwa, Hermann; Storch, Ursula; Demleitner, Jana et al. (2015) Phospholipase C epsilon (PLC?) induced TRPC6 activation: a common but redundant mechanism in primary podocytes. J Cell Physiol 230:1389-99
Dusaban, Stephanie S; Kunkel, Maya T; Smrcka, Alan V et al. (2015) Thrombin promotes sustained signaling and inflammatory gene expression through the CDC25 and Ras-associating domains of phospholipase C?. J Biol Chem 290:26776-83
Malik, S; deRubio, R G; Trembley, M et al. (2015) G protein ?? subunits regulate cardiomyocyte hypertrophy through a perinuclear Golgi phosphatidylinositol 4-phosphate hydrolysis pathway. Mol Biol Cell 26:1188-98
Kan, Wei; Adjobo-Hermans, Merel; Burroughs, Michael et al. (2014) M3 muscarinic receptor interaction with phospholipase C ?3 determines its signaling efficiency. J Biol Chem 289:11206-18

Showing the most recent 10 out of 27 publications